WEBSITE BSE:544197 NSE: Retail Inc. Year: 2007 Industry: Retailing My Bucket: Add Stock
Last updated: 15:40
No Notes Added Yet
1. Business Overview
JHS Svendgaard Retail Ventures Ltd. is engaged in the retail, trading, and distribution of Fast-Moving Consumer Goods (FMCG) across India. The company focuses on categories such as personal care, oral care, household products, and general merchandise. It acts as the distribution and marketing arm for products, including those manufactured by its group entity, JHS Svendgaard Laboratories Ltd., which is known for oral care products and holds licenses for international brands like Aquafresh and Aim in India, alongside developing its own brands such as Dr. Fresh. The company generates revenue through the sale of these products to consumers via various retail channels including traditional general trade, modern trade, and e-commerce platforms.
2. Key Segments / Revenue Mix
The primary revenue stream for JHS Svendgaard Retail Ventures Ltd. is derived from the sales and distribution of FMCG products. Given its lineage and group synergies, a significant portion of its sales are concentrated in the personal care and oral care segments, specifically toothbrushes, toothpaste, and related hygiene products under brands like Aquafresh (licensed for India) and Dr. Fresh. While specific segment-wise revenue breakdowns are not widely available for this demerged entity, its core business model revolves around driving sales and market penetration for its owned and licensed brands within the broader FMCG space.
3. Industry & Positioning
The company operates within the vast and intensely competitive Indian FMCG retail and distribution industry. This market is dominated by large, well-established multinational corporations (e.g., HUL, P&G, Colgate-Palmolive) and strong Indian conglomerates (e.g., ITC, Dabur, Marico, Patanjali) that possess extensive distribution networks and significant brand recall. JHS Svendgaard Retail Ventures is positioned as a niche-to-mid-tier player, aiming to capture market share through a focused approach on specific product categories, leveraging its group's manufacturing capabilities, and strategic brand licensing. It differentiates itself by potentially offering a range of products including both globally recognized licensed brands and value-for-money domestic brands.
4. Competitive Advantage (Moat)
Group Synergy & Backward Integration: The company benefits from a strong operational synergy with its demerged parent/group company, JHS Svendgaard Laboratories Ltd., which provides manufacturing expertise and product development capabilities, potentially leading to cost efficiencies and faster product-to-market cycles.
Brand Licensing: Holding exclusive licensing rights for established international oral care brands like Aquafresh and Aim for the Indian market provides instant brand recognition, consumer trust, and a readily available product portfolio with global appeal.
Distribution Network: The company is actively building and expanding its distribution channels across India, which, if efficiently scaled, can become a significant barrier to entry for new competitors in specific categories.
Focused Product Portfolio: A clear focus on specific segments like oral care allows for deeper market understanding and targeted marketing efforts, potentially leading to strong regional or category leadership.
5. Growth Drivers
Rising Disposable Income & Consumption: India's growing middle class, increasing urbanization, and rising disposable incomes are expected to fuel demand for FMCG products, including personal and oral care items.
Distribution Expansion: Expanding its reach into Tier 2, Tier 3 cities, rural markets, and strengthening its presence in modern trade and e-commerce channels will be crucial for growth.
New Product Development & Category Expansion: Introducing new products under existing brands or diversifying into adjacent FMCG categories to capture a larger share of consumer spending.
Brand Building Initiatives: Investing in marketing and advertising to enhance brand awareness and recall for its owned and licensed brands.
Digital Penetration: Leveraging the increasing digital literacy and e-commerce adoption in India to reach a wider customer base and reduce distribution costs.
6. Risks
Intense Competition: The Indian FMCG market is highly competitive, with numerous well-capitalized domestic and international players, leading to potential pricing pressure and market share battles.
Brand Dependency: A significant reliance on a few key brands (e.g., Aquafresh, Dr. Fresh) means that any decline in their popularity or adverse brand perception could materially impact revenues and profitability.
Changes in Consumer Preferences: Rapid shifts in consumer tastes, demand for specific ingredients (e.g., natural, organic), or health trends could necessitate costly product reformulations or marketing shifts.
Supply Chain & Manufacturing Risks: Dependencies on raw material sourcing and the manufacturing capabilities of its group company expose it to potential supply chain disruptions, quality control issues, or production inefficiencies.
Economic Slowdown: A downturn in the Indian economy could lead to reduced consumer spending on discretionary FMCG items, affecting sales growth.
Regulatory Changes: Changes in food and drug regulations, advertising standards, or taxation policies related to FMCG could impact operations and profitability.
7. Management & Ownership
The company is promoted by the Svendgaard family, with Mr. Nikhil Nanda, a key figure from the founding family of the larger JHS Svendgaard group, playing a significant role. The management team likely consists of experienced professionals in the FMCG sector who oversee the company's distribution, marketing, and operational strategies. The promoter group maintains a substantial ownership stake, indicating a strong alignment between management and shareholder interests for long-term growth and stability. The ownership structure typically reflects a promoter-controlled entity with public participation.
8. Outlook
JHS Svendgaard Retail Ventures Ltd. operates in a promising yet challenging Indian FMCG landscape. The bull case for the company is predicated on its ability to effectively capitalize on India's demographic dividend and rising consumption trends, leverage the established brand equity of its licensed international products (like Aquafresh), and efficiently expand its distribution network. Its direct access to manufacturing capabilities via its group company provides a cost and agility advantage. The bear case centers on the formidable competition from deeply entrenched players with vast resources, the continuous need for significant investment in brand building and distribution infrastructure, and the inherent volatility of consumer preferences in the FMCG sector. The company's future success will largely depend on its execution efficiency, ability to adapt to market dynamics, and skill in sustaining brand relevance and consumer trust amidst intense competition.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹16 Cr.
Stock P/E 136.4
P/B 1.1
Current Price ₹19.5
Book Value ₹ 18.2
Face Value 10
52W High ₹46.9
Dividend Yield 0%
52W Low ₹ 16
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Net Sales | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 |
| Other Income | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
| Total Income | 5 | 4 | 4 | 4 | 4 | 5 | 5 | 6 |
| Total Expenditure | 3 | 4 | 4 | 2 | 3 | 4 | 5 | 4 |
| Operating Profit | 1 | 0 | 0 | 2 | 1 | 1 | 0 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 0 | -1 | 2 | 1 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -0 | 0 | 0 | 0 | 0 | -1 | 0 |
| Provision for Tax | 1 | -0 | 0 | -0 | 0 | -0 | -0 | 0 |
| Profit After Tax | -0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Adjustments | -0 | -0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Profit After Adjustments | -0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Adjusted Earnings Per Share | -0.4 | -0.7 | 0.6 | 0.3 | 0.1 | 0.3 | -0.7 | 0.5 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Net Sales | 3 | 2 | 3 | 11 | 13 | 16 | 16 |
| Other Income | 3 | 1 | 1 | 3 | 4 | 5 | 5 |
| Total Income | 6 | 3 | 4 | 15 | 17 | 21 | 20 |
| Total Expenditure | 4 | 3 | 4 | 12 | 14 | 17 | 16 |
| Operating Profit | 1 | 0 | 0 | 3 | 3 | 4 | 3 |
| Interest | 0 | 1 | 0 | 1 | 0 | 1 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 3 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -2 | -1 | 1 | 0 | 0 | -1 |
| Provision for Tax | -0 | -0 | 0 | 0 | 0 | -0 | 0 |
| Profit After Tax | -0 | -2 | -1 | 1 | 0 | 0 | 0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -0 | -2 | -1 | 1 | 0 | 0 | 0 |
| Adjusted Earnings Per Share | -0.4 | -2.4 | -2.1 | 1.2 | 0.4 | 0.2 | 0.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 23% | 75% | 40% | 0% |
| Operating Profit CAGR | 33% | 0% | 32% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -51% | NA% | NA% | NA% |
| ROE Average | 2% | 7% | -8% | -7% |
| ROCE Average | 8% | 17% | 1% | 1% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Shareholder's Funds | 6 | 5 | 4 | 6 | 6 | 17 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 1 |
| Other Non-Current Liabilities | 3 | 2 | 2 | -0 | 0 | 2 |
| Total Current Liabilities | 3 | 2 | 1 | 2 | 1 | 6 |
| Total Liabilities | 12 | 9 | 7 | 8 | 8 | 26 |
| Fixed Assets | 5 | 2 | 1 | 1 | 1 | 6 |
| Other Non-Current Assets | 2 | 2 | 1 | 2 | 3 | 7 |
| Total Current Assets | 5 | 5 | 4 | 6 | 4 | 13 |
| Total Assets | 12 | 9 | 7 | 8 | 8 | 26 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 1 | 2 |
| Cash Flow from Operating Activities | 6 | -1 | -0 | 2 | 0 | -3 |
| Cash Flow from Investing Activities | -5 | 2 | 0 | -1 | 1 | -0 |
| Cash Flow from Financing Activities | -1 | -1 | -0 | -0 | -0 | 9 |
| Net Cash Inflow / Outflow | 0 | 0 | -0 | 1 | 1 | 6 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 1 | 2 | 8 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -0.35 | -2.37 | -2.07 | 1.15 | 0.39 | 0.17 |
| CEPS(Rs) | 1.38 | -0.1 | -0.6 | 3.38 | 3.87 | 4.26 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 9.14 | 7.07 | 5.69 | 9.46 | 9.89 | 11.83 |
| Core EBITDA Margin(%) | -64.19 | -54.84 | -38.08 | -1.81 | -5.2 | -6.4 |
| EBIT Margin(%) | 2.13 | -75.62 | -33.2 | 14.36 | 4.69 | 6.33 |
| Pre Tax Margin(%) | -13.26 | -108.89 | -47.95 | 9.75 | 2.23 | 0.06 |
| PAT Margin (%) | -8.73 | -82.56 | -49.05 | 6.58 | 1.95 | 0.73 |
| Cash Profit Margin (%) | 33.98 | -3.32 | -14.1 | 19.29 | 19.29 | 17.97 |
| ROA(%) | -1.95 | -14.86 | -17.07 | 10.03 | 3.21 | 0.69 |
| ROE(%) | -3.87 | -29.27 | -32.46 | 15.22 | 4.05 | 1.62 |
| ROCE(%) | 0.93 | -26.31 | -21.46 | 32.6 | 9.67 | 8.13 |
| Receivable days | 3.88 | 11.34 | 45.69 | 27.95 | 22.61 | 13.6 |
| Inventory Days | 67.8 | 74.76 | 41.88 | 15.81 | 19.54 | 22.14 |
| Payable days | 82.31 | 108.57 | 83.8 | 28.57 | 17.13 | 22.23 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 209.73 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 3.06 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 2.48 | 3.43 | 2.37 | 0.49 | 0.36 | 1.11 |
| EV/Core EBITDA(x) | 5.52 | 94.98 | 135.46 | 1.8 | 1.65 | 4.69 |
| Net Sales Growth(%) | 0 | -29.09 | 46.83 | 314.94 | 14.54 | 23.71 |
| EBIT Growth(%) | 0 | -2616.19 | 35.54 | 279.43 | -62.57 | 66.96 |
| PAT Growth(%) | 0 | -570.3 | 12.77 | 155.67 | -66.01 | -53.89 |
| EPS Growth(%) | 0 | -570.96 | 12.77 | 155.67 | -66.01 | -55.91 |
| Debt/Equity(x) | 0.02 | 0.02 | 0.03 | 0.01 | 0 | 0.16 |
| Current Ratio(x) | 1.81 | 2.04 | 3.39 | 2.54 | 3.95 | 2.02 |
| Quick Ratio(x) | 1.62 | 1.92 | 3.11 | 2.25 | 3.17 | 1.83 |
| Interest Cover(x) | 0.14 | -2.27 | -2.25 | 3.12 | 1.9 | 1.01 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0.05 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoter | 42.32 | 42.32 | 42.32 | 44.86 | 49.33 | 44.52 | 44.52 | 44.52 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 57.68 | 57.68 | 57.68 | 55.14 | 50.67 | 55.48 | 55.48 | 55.48 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoter | 0.28 | 0.28 | 0.28 | 0.31 | 0.37 | 0.37 | 0.37 | 0.37 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.46 | 0.46 | 0.46 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.65 | 0.65 | 0.65 | 0.68 | 0.74 | 0.82 | 0.82 | 0.82 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.